GlaxoSmithKline PLC
LSE:GSK
GlaxoSmithKline PLC
Other Operating Expenses
GlaxoSmithKline PLC
Other Operating Expenses Peer Comparison
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
GlaxoSmithKline PLC
LSE:GSK
|
Other Operating Expenses
-£180m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
AstraZeneca PLC
LSE:AZN
|
Other Operating Expenses
-$964m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Indivior PLC
LSE:INDV
|
Other Operating Expenses
$2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Other Operating Expenses
-$4m
|
CAGR 3-Years
55%
|
CAGR 5-Years
43%
|
CAGR 10-Years
24%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is GlaxoSmithKline PLC's Other Operating Expenses?
Other Operating Expenses
-180m
GBP
Based on the financial report for Mar 31, 2024, GlaxoSmithKline PLC's Other Operating Expenses amounts to -180m GBP.